title: Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study.
authors.affiliation: Keystone Dermatology Institute, Edmonton, AB. gesearles@mac.com
authors.forename: Gordon
authors.initials: G
authors.lastname: Searles
authors.forename: Robert
authors.initials: R
authors.lastname: Bissonnette
authors.forename: Ian
authors.initials: I
authors.lastname: Landells
authors.forename: Neil H
authors.initials: NH
authors.lastname: Shear
mesh_terms: D000077944:Alefacept; D002170:Canada / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D009017:Morbidity / Q000639:trends; D011565:Psoriasis / Q000188:drug therapy* / Q000453:epidemiology; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D011993:Recombinant Fusion Proteins; D000077944:Alefacept